Table 4.

Univariate Analysis

Covariate	Incidence Density Ratio for ARE (95% CI)	P Value
GERD	2.51 (1.45–4.35)	.001
Basiliximab and tacrolimus	0.51 (0.32–0.84)	.007
PGD score ≥2	0.69 (0.38–1.24)	.22
Recipient CMV (−)	1.86 (1.12–3.09)	.016
Native lung disease	1.00	.54
CF	2.19 (0.30–14.83)	.42
COPD	2.01 (0.27–13.71)	.48
ILD Other	1.31 (0.29–13.71)	.79
HLA mismatch (≥5)	1.07 (0.56–2.06)	.83